您好,欢迎访问三七文档
当前位置:首页 > 商业/管理/HR > 人事档案/员工关系 > 以百白破疫苗为基础的联合疫苗研究进展和展望
以百白破疫苗为基础的联合疫苗研究进展和展望作者:卫辰,侯启明,张庶民,陈平纡,马霄作者单位:卫辰,侯启明,张庶民,马霄(中国食品药品检定研究院血清室卫生部生物技术产品检定方法及其标准化重点实验室,北京,100050),陈平纡(兰州生物制品研究所有限责任公司)刊名:中华预防医学杂志英文刊名:ChineseJournalofPreventiveMedicine年,卷(期):2012,46(9)参考文献(23条)1.deMelkerHE;SchellekensJF;NeppelenbroekSEReemergenceofpertussisinthehighlyvaccinatedpopulationoftheNetherlands:observationsonsurveillancedata2000(04)2.骆鹏;张庶民百日咳免疫控制研究进展[期刊论文]-中国公共卫生2010(05)3.StanleyAP;WalterAO;梁晓峰;罗凤基,封多佳疫苗学20114.DeckerMD;EdwardsKM;BradleyRComparativetrialininfantsoffourconjugateHaemophilusinfluenzaetypebvaccines1992(2Pt1)5.ShinefieldH;BlackS;ThearMSafetyandimmunogenicityofameasles,mumps,rubellaandvaricellavaccinegivenwithcombinedHaemophilusinfluenzaetypebconjugate/hepatitisBvaccinesandcombineddiphtheria-tetanusacellularpertussisvaccines2006(04)6.MawasF;DickinsonR;Douglas-BardsleyAImmuneinteractionbetweencomponentsofacellularpertussis-diphtheria-tetanus(DTaP)vaccineandhaemophilusinfluenzaeb(Hib)conjugatevaccineinaratmodel[外文期刊]2006(17)7.EskolaJ;WardJ;DaganRCombinedvaccinationofhaemophilusinfluenzaetypebconjugateanddiphtheria-tetanus-pertussiscontainingacellularpertussis1999(9195)8.CarlssonRM;ClaessonBA;FagerlundEAntibodypersistenceinfive-year-oldchildrenwhoreceivedapentavalentcombinationvaccineininfancy2002(06)9.LiRC;LiFX;LiYPImmunogenicityandsafetyofapentavalentacellularpertussiscombinedvaccineincludingdiphtheria,tetanus,inactivatedpoliovirusandconjugatedHaemophilusInfluenzaetypebpolysaccharideforprimaryvaccinationat2,3,4or3,4,5monthsofageininfantsinChina2011(10)10.LiRC;LiFX;LiYPAntibodypersistenceat18-20monthsofageandsafetyandimmunogenicityofaboosterdoseofacombinedDTaP-IPV//PRP~Tvaccinecomparedtoseparatevaccines(DTaP,PRP~TandIPV)followingprimaryvaccinationofhealthyinfantsinthePeople'sRepublicofChina2011(50)11.TregnaghiMW;ZambranoB;Santos-LimaEImmunogenicityandsafetyofaninvestigationalhexavalentdiphtheria-tetanus-acellularpertussis-inactivatedpoliovirus-hepatitisB-HaemophilusinfluenzaeBconjugatecombinedvaccineinhealthy2-,4-,and6-month-oldArgentineaninfants2011(06)12.MacíasM;LanataCF;ZambranoBSafetyandimmunogenicityofaninvestigationalfullyliquidhexavalent:DTaPIPVHepBPRPTvaccineat2,4,6monthsofagecomparedtolicensedvaccinesinLatinAmerica201213.MadhiSA;MithaI;CutlandCImmunogenicityandsafetyofaninvestigationalfullyliquidhexavalentcombinationvaccineversuslicensedcombinationvaccinesat6,10and14weeksofageinhealthySouthAfricaninfants2011(04)14.KosalaraksaP;ThisyakornU;BenjaponpitakSImmunogenicityandsafetystudyofanewDTaP-IPV-HepBPRP-TcombinedvaccinecomparedtoalicensedDTaP-IPV-HepB//PRP-Tcomparator,bothconcomitantlyadministeredwitha7-valentpneumococcalconjugatevaccineat2,4,and6monthsofageinThaiinfants2011(04)15.HalperinSA;LangleyJM;HesleyTMSafetyandimmunogenicityoftwoformulationsofahexavalentdiphtheriatetanus-acellularpertussis-inactivatedpoliovirus-Haemophilusinfluenzaeconjugate-hepatitisBvaccinein15to18-month-oldchildren2005(06)16.HalperinSA;TapieroB;Diaz-MitomaFSafetyandimmunogenicityofahexavalentdiphtheria-tetanus-acellularpertussis-inactivatedpoliovirus-Haemophilusinfluenzaebconjugate-hepatitisBvaccineat2,3,4,and12-14monthsofage[外文期刊]2009(19)17.张庶民;侯启明;马霄吸附全细胞百白破乙肝四联疫苗效果观察[期刊论文]-中国公共卫生2003(09)18.李贵凡;郑海发;尹珊珊无细胞百白破b型流感嗜血杆菌联合疫苗的研制2008(09)19.EdwardsKM;MeadeBD;DeckerMDComparisonof13acellularpertussisvaccines:overviewandserologicresponse1995(3Pt2)20.GianniniG;RappuoliR;RattiGTheamino-acidsequenceoftwonon-toxicmutantsofdiphtheriatoxin:CRM45andCRM1971984(10)21.GreenbergDP;WongVK;PartridgeSSafetyandimmunogenicityofacombinationdiphtheria-tetanustoxoidsacellularpertussis-hepatitisBvaccineadministeredattwo,fourandsixmonthsofagecomparedwithmonovalenthepatitisBvaccineadministeredatbirth,onemonthandsixmonthsofage2002(08)22.GiammancoG;MoiraghiA;ZottiCSatetyandimmunogenicityofacombineddiphtheria-tetanus-acellularpertussis-hepatitisBvaccineadministeredaccordingtotwodifferentprimaryvaccinationschedules.MulticenterWorkingGroup1998(07)23.GylcaR;GylcaV;BenesOAnewDTPa-HBV-IPVvaccineco-administeredwithHib,comparedtoacommerciallyavailableDTPw-IPV/Hibvaccineco-administeredwithHBV,givenat6,10and14weeksfollowingHBVatbirth2000(7/8)引用本文格式:卫辰.侯启明.张庶民.陈平纡.马霄以百白破疫苗为基础的联合疫苗研究进展和展望[期刊论文]-中华预防医学杂志2012(9)
本文标题:以百白破疫苗为基础的联合疫苗研究进展和展望
链接地址:https://www.777doc.com/doc-1975605 .html